AI can adjust dosage for cancer patients

AI can adjust dosage for cancer patients

MIT researchers have developed an artificial intelligence (AI) system that can help reduce toxic chemotherapy dosing for the most aggressive form of brain cancer, potentially improving the quality of life for patients.

Glioblastoma is a malignant tumour that appears in the brain or spinal cord, and prognosis for adults is no more than five years.

Patients must endure a combination of radiation therapy and multiple drugs taken every month.

Medical professionals generally administer maximum safe drug doses to shrink the tumour as much as possible. However, these strong pharmaceuticals still cause debilitating side effects in patients.